CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-12 | Norry Elliot Chief Medical Officer | Sale | −841 | $6.15 | $5K | 1,396 |
| 2021-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,707 | $6.15 | $17K | 3,695 |
| 2021-01-11 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +1,086,816 | 1,086,816 | ||
| 2021-01-11 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +242,712 | 242,712 | ||
| 2021-01-11 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +1,086,816 | 1,086,816 | ||
| 2021-01-11 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +242,712 | 242,712 | ||
| 2021-01-11 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +3,260,400 | 3,260,400 | ||
| 2021-01-11 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +728,160 | 728,160 | ||
| 2021-01-11 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Grant or award · Option to purchase Ordinary Shares | +1,086,816 | 1,086,816 | ||
| 2021-01-11 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Grant or award · Option to purchase Ordinary Shares | +242,712 | 242,712 | ||
| 2021-01-11 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,086,816 | 1,086,816 | ||
| 2021-01-11 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +242,712 | 242,712 | ||
| 2021-01-11 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +1,086,816 | 1,086,816 | ||
| 2021-01-11 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +242,712 | 242,712 | ||
| 2021-01-04 | Lunger John Chief Patient Supply Officer | Sale | −1,065 | $5.33 | $6K | 1,760 |
| 2021-01-04 | Bertrand William C JR Chief Operating Officer | Sale | −3,499 | $5.33 | $19K | 5,864 |
| 2021-01-04 | Norry Elliot Chief Medical Officer | Sale | −845 | $5.33 | $5K | 1,392 |
| 2021-01-04 | Rawcliffe Adrian Chief Executive Officer | Sale | −4,967 | $5.33 | $26K | 6,737 |
| 2020-12-14 | Wood Gavin Chief Financial Officer | Purchase | +24,000 | $0.69 | $17K | 57,000 |
| 2020-12-14 | Bertrand William C JR Chief Operating Officer | Purchase | +207,000 | $0.69 | $144K | 284,808 |
Page 12 of 23 · 454 trades